Thursday, June 23, 2011

Novo Nordisk pays payola to pharmacists

Seems as though Novo Nordisk has a lot going on.  See this from the U.S. Attorney's Office (E.D. N.Y.):

Novo Nordisk, Inc. has entered into a civil settlement agreement with the United States in which it has agreed to pay the United States and several states $1.725 million to resolve allegations that the company caused false or fraudulent claims to be submitted to the Medicaid program in connection with its marketing of the diabetes drugs Novolin, Novolin 70/30, Novolog, and Novolog 70/30.

No comments:

Post a Comment